Dr. Corina Antal obtained her Ph.D. from the University of California, San Diego, where she overturned longstanding scientific dogma by revealing that members of the protein kinase C family act as tumor suppressors, contrary to their prior classification as oncogenes. During her postdoctoral research at the Salk Institute, she focused on uncovering and therapeutically targeting epigenetic vulnerabilities in pancreatic cancer. Recognized for her groundbreaking contributions, Dr. Antal was named to Forbes’ “30 Under 30” list in Science. In 2023, she returned to UC San Diego as an Assistant Professor in the Department of Pharmacology and a member of the Moores Cancer Center. Her laboratory investigates how dysregulation of RNA processing contributes to cancer development and progression.
Mailing List
